Shaklee Obtains Exclusive License for Liquid BioCell Collagen from BioCell Technology
Shaklee Expands Its Healthy Aging Portfolio With the Gold Standard in Liquid Collagen
Shaklee, the pioneer of the nutrition supplement industry, sought the exclusive license to ensure the best-selling product could continue to be available to its consumers.
"BioCell Technology, LLC congratulates Shaklee Corporation and Liquid Collagen Acquisition, LLC on being the winning bidder for the assets of Modere. The BioCell Technology, LLC team is proud and excited to work with Shaklee Corporation and Liquid Collagen Acquisition, LLC as its exclusive licensee to bring Liquid BioCell® Collagen to the world."
The licensing agreement is in effect immediately. All products will be available to purchase through Shaklee's network of ambassadors and on Shaklee.com.
About Shaklee
Shaklee is a leading wellness company founded by
About BioCell Technology, LLC
BioCell Technology, LLC is an award-winning research, product development, branding, and marketing company that manufactures innovative, science-based ingredients that have applications in dietary supplements, functional foods, and cosmetics. The company licenses its branded ingredients to leading consumer packaged goods companies for use in their finished products. For more information, visit www.BioCellTechnology.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/shaklee-obtains-exclusive-license-for-liquid-biocell-collagen-from-biocell-technology-302509818.html
SOURCE SHAKLEE CORPORATION
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- InterContinental Hotels Group PLC Announces Transaction in Own Shares - July 06
- Kosmos Energy Provides Operational Update
- H.I.G. Capital Signs Definitive Agreement to Acquire TERRAS
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share